Let's take a closer look at the scientific principles, technological progress, and translational hurdles defining the present state of microneedle research.
- Enhancing Gene And Cell Therapies With Circular RNA-Based Gene Expression
- Biomaterials In Ophthalmology Are Reshaping Ocular Drug Delivery
- Why Improving Drug Delivery Remains A Major Opportunity In Oncology
- Crossing The Brain's Barrier: Recent Advances And What Lies Ahead
- Navigating Combination Products: Device Complexity And Software Integration
- Improving Execution Of Biological Evaluation Of Drug Delivery Devices
- DDW 2026 Signalled The Next Era Of Competitive Landscape In IBD
- From Exosomes To Nanodrugs: Advancing Therapeutic Delivery For CNS Repair
ON-DEMAND WEBINARS
"One stop” sterile injectable fill/finish capabilities can accelerate timelines and reduce costs. Explore August Bio’s operational flexibility and available capacity to support small-, mid-size, and large-scale batches.
Developing new delivery routes is essential for creating more effective treatments. Nanoforming enables new routes to simplify dosing, enhance patient comfort, and reduce healthcare costs.
Through case studies on modified release, poor solubility, and pediatrics, discover how integrating GMP manufacturing and clinical testing can rapidly accelerate development timelines for even the most challenging of molecules.
Discover an advancement in the prefillable syringe market, uniquely integrating the syringe barrel, plunger, and needle shield/tip cap into a fully harmonized, verified system from a single supplier.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![West-2]( "The Path To Commercialization For Wearable Drug Delivery Devices")
The Path To Commercialization For Wearable Drug Delivery DevicesExplore the evolution of the wearable drug delivery market, including the route to commercialization and the challenges faced.
-
![iStock-1309776250-lab-research-development-team]( "Rational Design Of Oral Nanosuspensions For Insoluble Drugs")
Rational Design Of Oral Nanosuspensions For Insoluble DrugsThe advantages of nanosuspension dosage forms include improving bioavailability and API stability, increasing drug loading, better dose flexibility and accuracy, and easy swallowing for pediatric or geriatric populations.
-
![Nanoparticles GettyImages-622777274]( "Unlocking New Possibilities For Treating Rare Genetic Diseases")
Unlocking New Possibilities For Treating Rare Genetic DiseasesWith over 7,000 rare diseases, the potential for nanomedicine to revolutionize treatment is immense. While polymer nanoparticles hold great promise, several challenges remain.
-
![Assessing And Navigating Testing For Parenteral Packaging And Delivery Systems: Performance Testing]( "Best Practices For Ensuring Quality In Biologic Products")
Best Practices For Ensuring Quality In Biologic ProductsNew biologic therapies have new challenges in their packaging and delivery systems because of their complexities, higher stability risks, and larger sizes.
-
![GettyImages-1435081495-Self-Injector_Auto-Injector]( "Autoinjectors: A Revolutionary Leap In Drug Delivery")
Autoinjectors: A Revolutionary Leap In Drug DeliveryExplore how the widespread adoption of autoinjectors is transforming the biopharmaceutical industry's approach to drug delivery, offering precise dosing, patient adherence, and safety.
-
![respiratory]( "Trends In Combination Products")
Trends In Combination ProductsAs demand grows for more patient-centric drug delivery via self-administration, combination products are on the rise. Explore three major regulatory themes to consider when producing drug/device combination products.
-
![West-Vol 8-Blog]( "FAQs On The Revised EU GMP Annex 1: Volume 8")
FAQs On The Revised EU GMP Annex 1: Volume 8Successfully implementing a site-wide CCS requires prioritizing barrier technologies, integrating primary packaging into risk assessments, and adopting a data-driven approach to environmental monitoring.
-
![GettyImages-1371993517-syringe-vial-mask-vaccine-inject]( "Advancing Chronic Care Through GLP‑1 Innovation")
Advancing Chronic Care Through GLP‑1 InnovationGLP‑1 therapies are changing injectable care and driving rapid progress in delivery and manufacturing. See how patient needs, emerging tech, and regulations are reshaping chronic treatment.
-
![I02_michigan injmolding floor-REVISED-a (3)]( "Implementing Medium And High-Volume Drug Handling And Packaging Programs")
Implementing Medium And High-Volume Drug Handling And Packaging ProgramsSimplify the complexity of combination product development by partnering for integrated support across device design, industrialization, manufacturing, and final product assembly.
-
![GettyImages-1316775813-vial-production]( "Lyophilized Products Are On The Rise: What You Need To Know")
Lyophilized Products Are On The Rise: What You Need To KnowThere is increased demand for lyophilization services in the manufacturing of new biologic drugs and injectable formulations as well as in change of formulation presentation.
TOM'S TAKES ON DRUG DELIVERY
TALKING WITH TOM VIDEOCASTS
Fran offers keen industry and technical insights exclusively on Drug Delivery Leader.
DELIVERED BY DEGRAZIO
-
![Delivered _by _DeGrazio_Logo_Color_2]( "Procuring Packaging And Delivery Systems: Single Versus Dual Sourcing")
Procuring Packaging And Delivery Systems: Single Versus Dual SourcingIn this article, Fran DeGrazio examines the trend toward dual sourcing of products, components, and materials for drug delivery packaging and systems. She outlines the key differences between single and dual sourcing and makes recommendations about using one versus the other while mitigating supply chain and product quality risk.
FREE EBOOK: COMBINATION PRODUCTS
Combination products provide significant avenues for increasing patient adherence and overall efficacy. This collection outlines the opportunity and identifies strategies for gaining regulatory approval.
